HTG Molecular Diagnostics... (HTGM)
0.48
0.00 (0.00%)
At close: Jun 14, 2023, 8:00 PM
0.00% (1D)
| Bid | n/a |
| Market Cap | 1.06M |
| Revenue (ttm) | 6.21M |
| Net Income (ttm) | -20.15M |
| EPS (ttm) | -17.1 |
| PE Ratio (ttm) | -0.028070175438596492 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 725,429 |
| Avg. Volume (20D) | 253,915 |
| Open | 0.57 |
| Previous Close | 0.48 |
| Day's Range | 0.48 - 0.48 |
| 52-Week Range | 0.46 - 24.96 |
| Beta | 0.99 |
About HTGM
HTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables comprising assay kits; and software that automate sample processing and profiles various molecular targets. Its marketed molecular profiling panels include HTG Transcriptome Panel; HTG EdgeSeq precision immuno-oncology panel; HTG EdgeSeq miRNA whole-transcriptome assay; HTG EdgeSeq DLBCL cell of origin assay EU; ...
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date May 6, 2015
Employees 53
Stock Exchange NASDAQ
Ticker Symbol HTGM
Website https://www.htgmolecular.com